Gujarat Themis Biosyn Limited — Dividend/Bonus, 01-08-2025: Record Date

Gujarat Themis Biosyn's Board set September 5, 2025, as the record date for shareholders to be eligible for the dividend for the financial year ended March 31, 2025. In a strategic shift, the company has decided *not* to proceed with its proposed merger with Themis Medicare, choosing instead to intensely focus on its core fermentation-based pharmaceutical intermediates business. For the quarter ended June 30, 2025, the company reported a total income of ₹36.15 Cr and a net profit of ₹9.06 Cr. EPS stood at ₹0.83.